Cargando…

In vivo clearance of surfactant lipids during acute pulmonary inflammation.

BACKGROUND: A decrease in pulmonary surfactant has been suggested to contribute to the lung dysfunction associated with pulmonary inflammation. A number of studies have implicated surfactant clearance as a possible mechanism for altered pool sizes. The objective of the current study was to specifica...

Descripción completa

Detalles Bibliográficos
Autores principales: Malloy, Jaret L, Wright, Jo Rae
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC517704/
https://www.ncbi.nlm.nih.gov/pubmed/15357882
http://dx.doi.org/10.1186/1465-9921-5-8
_version_ 1782121783428644864
author Malloy, Jaret L
Wright, Jo Rae
author_facet Malloy, Jaret L
Wright, Jo Rae
author_sort Malloy, Jaret L
collection PubMed
description BACKGROUND: A decrease in pulmonary surfactant has been suggested to contribute to the lung dysfunction associated with pulmonary inflammation. A number of studies have implicated surfactant clearance as a possible mechanism for altered pool sizes. The objective of the current study was to specifically investigate the mechanisms of surfactant clearance in a rodent model of acute pulmonary inflammation. METHODS: Inflammation was induced by intrapulmonary instillation of lipopolysaccharide (LPS: 100 μg/kg). Lipid clearance was assessed at 18 and 72 hours post-LPS instillation by intratracheal administration of radiolabel surfactant-like liposomes 2 hours prior to isolation and analysis of inflammatory cells and type II cells. RESULTS: At both 18 and 72 hours after LPS instillation there was significantly less radioactivity recovered in the lavage fluid compared to respective control groups (p < 0.05). At both time points, the number of cells recovered by lavage and their associated radioactivity was greater compared to control groups (p < 0.01). There was no difference in recovery of radioactivity by isolated type II cells or other cells obtained from enzymatic digestion of lung tissue. CONCLUSION: These results show that increased clearance of surfactant lipids in our model of acute pulmonary inflammation is primarily due to the inflammatory cells recruited to the airspace and not increased uptake by alveolar type II cells.
format Text
id pubmed-517704
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-5177042004-09-19 In vivo clearance of surfactant lipids during acute pulmonary inflammation. Malloy, Jaret L Wright, Jo Rae Respir Res Research BACKGROUND: A decrease in pulmonary surfactant has been suggested to contribute to the lung dysfunction associated with pulmonary inflammation. A number of studies have implicated surfactant clearance as a possible mechanism for altered pool sizes. The objective of the current study was to specifically investigate the mechanisms of surfactant clearance in a rodent model of acute pulmonary inflammation. METHODS: Inflammation was induced by intrapulmonary instillation of lipopolysaccharide (LPS: 100 μg/kg). Lipid clearance was assessed at 18 and 72 hours post-LPS instillation by intratracheal administration of radiolabel surfactant-like liposomes 2 hours prior to isolation and analysis of inflammatory cells and type II cells. RESULTS: At both 18 and 72 hours after LPS instillation there was significantly less radioactivity recovered in the lavage fluid compared to respective control groups (p < 0.05). At both time points, the number of cells recovered by lavage and their associated radioactivity was greater compared to control groups (p < 0.01). There was no difference in recovery of radioactivity by isolated type II cells or other cells obtained from enzymatic digestion of lung tissue. CONCLUSION: These results show that increased clearance of surfactant lipids in our model of acute pulmonary inflammation is primarily due to the inflammatory cells recruited to the airspace and not increased uptake by alveolar type II cells. BioMed Central 2004 2004-07-23 /pmc/articles/PMC517704/ /pubmed/15357882 http://dx.doi.org/10.1186/1465-9921-5-8 Text en Copyright © 2004 Malloy and Wright; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Malloy, Jaret L
Wright, Jo Rae
In vivo clearance of surfactant lipids during acute pulmonary inflammation.
title In vivo clearance of surfactant lipids during acute pulmonary inflammation.
title_full In vivo clearance of surfactant lipids during acute pulmonary inflammation.
title_fullStr In vivo clearance of surfactant lipids during acute pulmonary inflammation.
title_full_unstemmed In vivo clearance of surfactant lipids during acute pulmonary inflammation.
title_short In vivo clearance of surfactant lipids during acute pulmonary inflammation.
title_sort in vivo clearance of surfactant lipids during acute pulmonary inflammation.
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC517704/
https://www.ncbi.nlm.nih.gov/pubmed/15357882
http://dx.doi.org/10.1186/1465-9921-5-8
work_keys_str_mv AT malloyjaretl invivoclearanceofsurfactantlipidsduringacutepulmonaryinflammation
AT wrightjorae invivoclearanceofsurfactantlipidsduringacutepulmonaryinflammation